For the quarter ending 2025-11-30, DSNY had $244,611 increase in cash & cash equivalents over the period. $298,275 in free cash flow.
| Cash Flow | 2025-11-30 | 2025-08-31 |
|---|---|---|
| Net income (loss) attributable to parent | 83,652 | -637,877 |
| Depreciation and amortization | 172,485 | 833,614 |
| Share-based payment arrangement, noncash expense | 1,333 | 31,728 |
| Amount of allowance for doubtful amounts | - | 51,055 |
| Allowance for doubtful accounts | 1,490 | - |
| Unrealized foreign exchange gain | 893 | -1,979 |
| Accounts receivable | 26,964 | 247,398 |
| Other receivables | -105,230 | 46,436 |
| Prepaid expenses and deposits | -14,707 | -47,178 |
| Accounts payable (increasedecreaseinaccountspayable) | 26,532 | -79,026 |
| Accrued liabilities (increasedecreaseinaccruedliabilities) | -68,694 | 110,690 |
| Deferred revenue (increasedecreaseindeferredrevenue) | -10,278 | -351 |
| Net cash provided by operating activities | 298,600 | 65,156 |
| Development of software | 29,802 | 306,052 |
| Purchase of property, equipment, and intangibles | 325 | 29,132 |
| Net cash used in investing activity | -30,127 | -335,184 |
| Common stock repurchased for cancellation | - | 0 |
| Net cash provided by (used in) financing activities | 0 | 0 |
| Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents, including disposal group and discontinued operations | -23,862 | -93,665 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | 244,611 | -363,693 |
| Cash and cash equivalents at beginning of period | 1,117,889 | 1,481,582 |
| Cash and cash equivalents at end of period | 1,362,500 | 1,117,889 |